Citidine-5-diphosphocholine or
citicoline (
CDP-choline) is used as a neuroprotective and memory-enhancing
drug in
cerebral stroke,
Alzheimer's disease, and other neurovascular diseases. Non-clinical studies have demonstrated the
neuroprotective effects of
CDP-choline in ischemic animal models. However, the relationship between the
neuroprotective effect and the memory enhancing effect of
CDP-choline is still unknown. No studies have demonstrated the ameliorative effect on impaired spatial memory and the suppressive effect on neuronal cell death of
CDP-choline in the same model. In this study, we examined the effect of
CDP-choline on impaired spatial memory and hippocampal CA1 neuronal death in rats subjected to repeated
cerebral ischemia, and we compared the mechanism of
CDP-choline to that of
donepezil. Seven days post administration of
CDP-choline (100, 300, 1000 mg/kg per day, p.o.) or
donepezil increased correct choices and reduced error choices in an eight-arm radial maze task in a dose-dependent manner. Neuronal cell death of
caspase-3 protein-positive neurons in the hippocampus were reduced by repeated administration of
CDP-choline at the highest dose. These results suggest that
CDP-choline has ameliorative effects on the impairment of spatial memory via hippocampal neuronal cell death in a rat model of
cerebral ischemia.